KRAS and non-small cell lung carcinoma: We chose to evaluate this hypothesis in an in vivo system, because the association between KRAS mutation and resistance to PI was not observed in vitro in our experiments with the isogenic SW48 cell lines, or in a group of 20 (17 primary and 3 cell line derived) NSCLC models evaluated using soft agar colony formation assays.